JP Morgan Chase
TECX

JP Morgan Chase’s Tectonic Therapeutic TECX Stock Holding History

JP Morgan Chase’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.7M Buy
58,870
+53,091
+919% +$1.31M ﹤0.01% 4232
2025
Q4 		$121K Sell
5,779
-145
-2% -$2.69K ﹤0.01% 5787
2025
Q3 		$92.9K Sell
5,924
-624
-10% -$12.9K ﹤0.01% 5942
2025
Q2 		$130K Buy
6,548
+5,426
+484% +$110K ﹤0.01% 5479
2025
Q1 		$19.9K Sell
1,122
-122
-10% -$3.98K ﹤0.01% 6152
2024
Q4 		$57.4K Buy
1,244
+1,222
+5,555% +$51.7K ﹤0.01% 5963
2024
Q3 		$667 Hold
22
– – ﹤0.01% 6774
2024
Q2 		$362 Sell
22
-2
-8% -$32 ﹤0.01% 6717
2024
Q1 		$361 Hold
24
– – ﹤0.01% 6755
2023
Q4 		$384 Sell
24
-6,961
-100% -$120K ﹤0.01% 6957
2023
Q3 		$129K Sell
6,985
-4,828
-41% -$85.4K ﹤0.01% 5332
2023
Q2 		$135K Sell
11,813
-5,519
-32% -$62.4K ﹤0.01% 5312
2023
Q1 		$208K Buy
17,332
+15,365
+781% +$214K ﹤0.01% 5045
2022
Q4 		$17K Sell
1,967
-3,755
-66% -$33K ﹤0.01% 5931
2022
Q3 		$44K Sell
5,722
-170,948
-97% -$1.9M ﹤0.01% 5593
2022
Q2 		$1.95M Buy
176,670
+10,471
+6% +$123K ﹤0.01% 3567
2022
Q1 		$2.63M Sell
166,199
-211,837
-56% -$4.38M ﹤0.01% 3538
2021
Q4 		$17.5M Sell
378,036
-6,098
-2% -$350K ﹤0.01% 1928
2021
Q3 		$25.7M Sell
384,134
-23,226
-6% -$1.91M ﹤0.01% 1572
2021
Q2 		$43.5M Sell
407,360
-3,611
-0.9% -$428K 0.01% 1284
2021
Q1 		$62.6M Buy
410,971
+35,492
+9% +$5.77M 0.01% 1064
2020
Q4 		$62.8M Buy
375,479
+72,564
+24% +$12.9M 0.01% 983
2020
Q3 		$48.5M Buy
302,915
+53,975
+22% +$10.9M 0.01% 990
2020
Q2 		$52.1M Buy
248,940
+32,982
+15% +$6.8M 0.01% 871
2020
Q1 		$40.3M Buy
215,958
+37,159
+21% +$8.75M 0.01% 896
2019
Q4 		$43.2M Buy
178,799
+14,858
+9% +$2.86M 0.01% 1043
2019
Q3 		$27.8M Buy
163,941
+43,263
+36% +$9.79M 0.01% 1343
2019
Q2 		$22.2M Buy
120,678
+18,640
+18% +$4.02M ﹤0.01% 1493
2019
Q1 		$27M Buy
102,038
+48,553
+91% +$8.88M 0.01% 1334
2018
Q4 		$10.7M Buy
53,485
+8,708
+19% +$2.65M ﹤0.01% 1956
2018
Q3 		$27.9M Buy
44,777
+17,654
+65% +$7.83M 0.01% 1401
2018
Q2 		$9.3M Buy
+27,123
New +$9.78M ﹤0.01% 2199

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

JP Morgan Chase's TECX Position: Q1 2026 in Review

JP Morgan Chase increased its Tectonic Therapeutic (TECX) stake by 919% in Q1 2026, buying an estimated $1.31M and bringing the position to 58,870 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #4232.

JP Morgan Chase first reported a position in TECX in Q2 2018 and has held it in 32 quarters since. The position peaked at $62.8M in Q4 2020. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • JP Morgan Chase held 58,870 shares of Tectonic Therapeutic worth $1.7M as of Q1 2026.
  • JP Morgan Chase bought 53,091 Tectonic Therapeutic shares in Q1 2026, an estimated $1.31M.
  • Tectonic Therapeutic made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4232 holding.
  • JP Morgan Chase first reported a position in Tectonic Therapeutic in Q2 2018 and has held it in 32 quarters since.
  • JP Morgan Chase's Tectonic Therapeutic position peaked at $62.8M in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.